Patient-reported outcomes are superior in patients with Type 2 diabetes treated with liraglutide as compared with exenatide, when added to metformin, sulphonylurea or both: results from a randomized, open-label study

W. E. Schmidt, J. S. Christiansen, M. Hammer, M. J. Zychma and J. B. Buse

Diabetic Medicine 28 ( 6 ): 715 - 723 , 2011